News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
High response rates in poor-risk population – Hagop Kantarjian
Photo of Dr. Hagop Kantarjian from obroncology.com
Jul 22, 2023, 17:56

High response rates in poor-risk population – Hagop Kantarjian

Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML & MDS/CMML after HMA failure. High response rates in poor-risk population. Data from randomized ph3 study in AML are awaited.

For article: Click here

Source: Hagop Kantarjian/Twitter

cancer Hagop Kantarjian Leukemia OncoDaily Oncology pevonedistat Research
Special Coverage
Blog
Mar 29, 2025, 12:32
Flavio Rocha: Inspiring presidential address by Ronald de Matteo at SSO2025
Blog
Mar 29, 2025, 12:27
Catherine Alix-Panabières: Honored to moderate at ESMO European Lung Cancer Congress 2025
Blog
Mar 29, 2025, 12:06
Loay Kassem: Who should be the first author of the manuscript?
Insight
Mar 29, 2025, 12:00
Surgery may not be necessary to treat invasive breast cancer
Blog
Mar 29, 2025, 11:58
Uta Schmidt-Straßburger: Insights from the Digital Health Innovation Forum
Radiotherapy
Mar 29, 2025, 11:54
Is Brachytherapy Right for You? The Science, Benefits, and Drawbacks Explained
Societies
Mar 29, 2025, 11:36
Patient-Reported Outcomes: ASCO Guideline is now available for Open Comment
Blog
Mar 29, 2025, 11:26
Insights from Axios' 4th Annual What's Next Summit by Lisa A. Lacasse
Blog
Mar 29, 2025, 11:25
Join Christine Iacobuzio-Donahue and Christine Lovly for AACR25 Professional Advancement Session: Cancer Discovery
Blog
Mar 29, 2025, 11:03
Emma Lande - Beating Cancer Twice Before 22 and Inspiring Hope
Blog
Mar 29, 2025, 11:01
Alique Topalian: Clinically-based oncology primary care and survivorship fellowships at the University of Cincinnati
Societies
Mar 29, 2025, 10:55
Meet the New AACR Board of Directores for 2025-2028 Term